First-pass extracted concept

CRISPR/Cas9 gene editing systems

Candidate: concept label1 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

CRISPR/Cas9 systems

Extracted Explainers

What the tool is doing

The paper describes CRISPR/Cas9 as a gene editing system used in modern genetic research and studied for cancer therapy.

Source 1DOI PubMed

What problem it solves

It is presented as a platform for gene editing applications relevant to malignant tumors.

Source 1DOI PubMed

Alternatives

The abstract does not name alternative gene editing systems.

Source 1DOI PubMed

Evidence Snippets

CRISPR/Cas9 systems can be categorized into three main delivery forms

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1application relevancesupports2025Source 1DOI PubMed

CRISPR/Cas9 gene editing systems have been extensively studied in the context of cancer therapy.

Quoted textsource-backed

CRISPR and CRISPR-associated protein 9 (Cas9) gene editing systems are among the most prevalent tools in modern genetic research and have been extensively studied in the context of cancer therapy.

Claim 2categorizationsupports2025Source 1DOI PubMed

CRISPR/Cas9 systems can be categorized into three main delivery forms: plasmid DNA containing Cas9 and sgRNA, Cas9 mRNA with sgRNA, and Cas9/sgRNA ribonucleoprotein complexes.

Quoted textsource-backed

CRISPR/Cas9 systems can be categorized into three main delivery forms: plasmid DNA (pDNA) containing both Cas9 and guide RNA (sgRNA), messenger RNA (mRNA) of Cas9 along with sgRNA, and ribonucleoprotein (RNP) complexes consisting of Cas9 protein bound to sgRNA.

Claim 3review scopesupports2025Source 1DOI PubMed

The article reviews CRISPR/Cas9 systems with a focus on non-viral, especially nanocarrier, delivery strategies, common delivery protocols, and delivery challenges.

Quoted textsource-backed

This article will review the various CRISPR/Cas9 systems, focusing on the non-viral especially nanocarrier delivery strategies and common protocols used for their delivery and the challenges encountered during this process.